Different clinical prognostic factors are associated with improved glycaemic control: findings from MARCH randomized trial.

about

Different clinical prognostic factors are associated with improved glycaemic control: findings from MARCH randomized trial.

Item

http://www.wikidata.org/entity/Q39790288

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Different clinical prognostic ...... s from MARCH randomized trial.

@en

Different clinical prognostic ...... s from MARCH randomized trial.

@nl

type

Item

label

Different clinical prognostic ...... s from MARCH randomized trial.

@en

Different clinical prognostic ...... s from MARCH randomized trial.

@nl

prefLabel

Different clinical prognostic ...... s from MARCH randomized trial.

@en

Different clinical prognostic ...... s from MARCH randomized trial.

@nl

P1476

Different clinical prognostic ...... s from MARCH randomized trial.

@en

P2093

F Liu

http://www.w3.org/2001/XMLSchema#string

H Yu

http://www.w3.org/2001/XMLSchema#string

J Han

http://www.w3.org/2001/XMLSchema#string

J Pang

http://www.w3.org/2001/XMLSchema#string

W Jia

http://www.w3.org/2001/XMLSchema#string

W Yang

http://www.w3.org/2001/XMLSchema#string

Y Bao

http://www.w3.org/2001/XMLSchema#string

Y Tu

http://www.w3.org/2001/XMLSchema#string

P2860

Standards of medical care in diabetes--2012

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?

Standards of medical care in diabetes--2010.

Effects of medical therapies on retinopathy progression in type 2 diabetes

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

P304

490-499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DME.13154

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27151271

http://www.w3.org/2001/XMLSchema#string